- Case report
- Open Access
Laparoscopic hepatopancreaticoduodenectomy for synchronous gallbladder cancer and extrahepatic cholangiocarcinoma: a case report
World Journal of Surgical Oncology volume 20, Article number: 190 (2022)
Hepatopancreaticoduodenectomy (HPD) is one of the most complex procedures, and it is very rarely reported. Laparoscopic HPD (LHPD) is even rarer. To date, there are only 3 reports of LHPD for locally advanced gallbladder cancer (GBC) or extrahepatic cholangiocarcinoma (ECC). This is the first report of LHPD for synchronous GBC and ECC.
A 75-year-old female patient complained of jaundice for 2 weeks without fever or abdominal pain. She was diagnosed with synchronous GBC and ECC. After a comprehensive preparation, she underwent a laparoscopic pancreaticoduodenectomy and resection of hepatic segments of IVb and V, and her digestive tract reconstruction followed Child’s methods. She was discharged on the 12th day postoperatively without pancreatic leakage, biliary leakage, or liver failure.
LHPD is safe and feasible for selected cases of GBCs or ECCs.
Hepatopancreaticoduodenectomy (HPD) is one of the most complicated operations which includes hepatectomy and pancreaticoduodenectomy. This operation was first reported in 1974 by Kasumi for locally advanced gallbladder cancer (GBC) . Almost half a century passed, this procedure was not universally accepted. In total, no more than 1000 HPDs have been reported [2, 3] for the past 50 years because of the high morbidity and mortality [4,5,6]. After a comprehensive search of PubMed using the terms of laparoscopy, hepatopancreaticoduodenectomy, hepatopancreatoduodenectomy, hepatopancreatectomy, pancreaticoduodenectomy, and hepatectomy, there were only 3 reports [7,8,9] involving 3 laparoscopic HPDs (LHPD) for locally advanced GBC or extrahepatic cholangiocarcinoma (ECC) which were list in detail in Table 1. To our knowledge, this case is the first LHPD for concurrent GBC and ECC.
A 75-year-old female patient complained of jaundice without fever or abdominal pain for 2 weeks and was diagnosed with ECC with GBC by enhanced CT and MRI. She denied any history of cardiovascular or pulmonary system problems. Her physical examination was negative except for jaundice of her skin and sclera. Her routine laboratory tests were as follows: hemoglobin 108 g/L, total bilirubin 222.8 μmol/L, direct bilirubin 158 μmol/L, plasma albumin 35.2 g/L, ALT 297 U/L, AST 192 U/L, ALP 403 U/L, and γGGT 394 U/L. Her tumor markers were normal, except for a mildly elevated Ca19-9 of 34.06 U/ml. Her hemostatic function was normal. An enhanced CT and MRI revealed that there was irregular thickening of the common bile duct wall and the gallbladder (Fig. 1). Cytological examination by ERCP was performed with the result of a malignant tumor of the lower common bile duct.
The patient was placed in a supine position with the legs split. Five ports were employed for the operation with an additional port located subxiphoid for splitting the liver. First, resection of the gallbladder was planned and then fast-frozen pathology was performed due to the presence of a malignant tumor. Pancreaticoduodenectomy was performed by artery-first approach. First, the superior mesenteric artery was retropancreatically dissected, the stomach and pancreatic neck were transected, and finally, the common hepatic duct was transected. The hepatectomy was performed along the intrahepatic Glissonean pedicle. The ligamentum teres hepatis was dissected to reveal the pedicle of a segment of IVb. The pedicle was transected, and the liver was continuously split until reaching the right anterior branch of the portal vein. Split liver and transected middle hepatic vein to further reveal the pedicle of segment V and then transected it (Fig. 1).
Reconstruction was performed following Child’s methods. Pancreaticojejunostomy was completed by the modified Blumgart method. Cholangiojejunostomy was completed by 4–0 polydioxanone in a manner of a continuous suture. The gastroenterostomy was completed by an endolinear stapler.
The operation lasted 380 min with an estimated blood loss of 400 ml. Her postoperative treatment followed the principle of enhanced recovery after the operation (ERAS). Her recovery was smooth without pancreatic leakage, biliary leakage, or liver failure. She was discharged on the 12th day postoperatively. The pathology revealed synchronous adenosquamous carcinoma of the gallbladder and common bile duct. This pathological result was finally given after a comprehensive discussion. The diagnosis of adenosquamous carcinoma was based on immunohistochemistry which showed both squamous cell carcinoma and adenocarcinoma. The diagnosis of dual original carcinoma instead of GBC with seeding metastasis to a common biliary duct was based on the fact of extensive lesion of the lower biliary duct without a clear boundary.
The indications for hepatopancreatoduonectomy (HPD) are locally advanced gallbladder cancer (GBC) and locally advanced extrahepatic cholangiocarcinoma (ECC) . HPD is one of the most challenging procedures, which includes pancreaticoduodenectomy (PD) and hepatectomy. This combination results in a dramatic increase in the morbidity and mortality, especially in the risk of liver failure [4,5,6], which prevents its use. As reported, the morbidity of HPD is as high as 80%, and the in-hospital mortality may be more than 10% . This rate is far higher than that of other operations, such as hepatectomy and PD. However, this increased mortality may be a result of the major hepatectomy, as the results from HPD with minor hepatectomy showed no increases in the mortality . The survival results were promising for the patients who had HPD. The 3-year and 5-year overall survival rates were reported to be 48% and 37% , respectively, which were significantly higher than those of unresectable tumors . The prolonged survival has encouraged surgeons to try this procedure.
As laparoscopic techniques have progressed, more and more complicated operations are completed by laparoscopy [13, 14] with an acceptable complication. Post-operation pancreatic leakage is considered to be the biggest obstacle to PD. Resent years, several modifications [15, 16] of pancreaticojejunostomy have been published to lessen the complication with success. Now, more and more laparoscopic pancreaticoduodenectomy (LPD) are reported with less pancreatic leakage and less blood loss . The laparoscopic anatomic hepatectomy (LAH) also results in less blood loss and faster recovery . In recent years, we have routinely carried out these complicated operations; therefore, we first adopted laparoscopy for HPD with success. LHPD has only been reported for 3 patients with locally advanced GBC or ECC, which were considered the main indications . All the 3 operations were successful with acceptable complications which were listed in detail in Table 1. This was the first LHPD for concurrent GBC and ECC. Our experience showed that LHPD was safe and feasible. Our successful performance of the LHPD may be based on two factors. First, surgeon preparation should be emphasized. Surgeons who are interested in LHPD should be skilled in both LPD and LAH. Well-trained surgeons can perform LPD fluently with less morbidity . LAH was also reported to lower morbidity following the intrahepatic Glissonean approach by skilled surgeons . Only surgeons who were skilled at both of the complicated procedures can perform LHPD with safety. Second, the patient selection is important. As the increased morbidity may be secondary to the major hepatectomy, this combination of operations should be limited to a minor hepatectomy. Those patients who need a major hepatectomy should undergo a preoperative portal vein embolism (PVE). The results from patients who had a preoperative PVE showed less morbidity and less in-hospital mortality . Preoperative bile drainage is controversial, as no significant advantage was shown according to published data . Preoperative bile drainage should be recommended for those patients who need major hepatectomy or those with cholangitis , as jaundice may affect the remnant liver function . Patients who plan to undergo LHPD should be at good performance status. The case reported here by our team was an elderly female patient who had no limitations in her daily life.
According to the published cases and our experience, LHPD is safe and feasible by specially skilled surgeons. LHPD should be an option for selected patients with GBC or ECC.
Availability of data and materials
All data generated or analyzed during this study are included in this published article.
Enhanced recovery after an operation
Laparoscopic anatomic hepatectomy
Portal vein embolism
Kasumi F, Takagi K, Konishi T, Sakamoto G. Treatment of gallbladder cancer. Jpn J Gastroenterol Surg. 1976;9:170–7.
Fancellu A, Sanna V, Deiana G, Ninniri C, Turilli D, Perra T, et al. Current role of hepatopancreatoduodenectomy for the management of gallbladder cancer and extrahepatic cholangiocarcinoma: a systematic review. World J Gastrointest Oncol. 2021;13:625–37.
Zhou Y, Zhang Z, Wu L, Li B. A systematic review of safety and efficacy of hepatopancreatoduodenectomy for biliary and gallbladder cancers. HPB. 2016;18:1–6.
Dai WC, Chok KS, Cheung TT, Chan AC, Chan SC, Lo CM. Hepatopancreatoduodenectomy for advanced hepatobiliary malignancies: a single-center experience. Hepatobiliary Pancreat Dis Int. 2017;16:382–6.
Welch JC, Gleeson EM, Karachristos A, Pitt HA. Hepatopancreatoduodenectomy in North America: are the outcomes acceptable? HPB. 2020;22:360–7.
D’Souza MA, Valdimarsson VT, Campagnaro T, Cauchy F, Chatzizacharias NA, D’Hondt M, et al. Hepatopancreatoduodenectomy - a controversial treatment for bile duct and gallbladder cancer from a European perspective. HPB. 2020;22:1339–48.
Zhang MZ, Xu XW, Mou YP, Yan JF, Zhu YP, Zhang RC, et al. Resection of a cholangiocarcinoma via laparoscopic hepatopancreatoduodenectomy: a case report. World J Gastroenterol. 2014;20:17260–4.
Chong EH, Choi SH. Hybrid laparoscopic and robotic hepatopancreaticoduodenctomy for cholangiocarcinoma. J Gastrointest Surg. 2019;23:1947–8.
James M, Kalayarasan R, Gnanasekaran S, Pottakkat B. Laparoscopic hepatopancreatoduodenectomy for locally advanced gall bladder cancer. J Min Access Surg. 2021;17:369–72.
Hemming AW, Magliocca JF, Fujita S, Kayler LK, Hochwald S, Zendejas I, et al. Combined resection of the liver and pancreas for malignancy. J Am Coll Surg. 2010;210:808–14.
Shimizu A, Motoyama H, Kubota K, Notake T, Fukushima K, Ikehara T, et al. Safety and oncological benefit of hepatopancreatoduodenectomy for advanced extrahepatic cholangiocarcinoma with horizontal tumor spread: Shinshu University Experience. Ann Surg Oncol. 2021;28:2012–25.
Fiteni F, Jary M, Monnien F, Nguyen T, Beohou E, Demarchi M, et al. Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy. BMC Gastroenterol. 2014;14:143.
Morano WF, Shaikh MF, Gleeson EM, Galvez A, Khalili M, Lieb J, et al. Reconstruction options following pancreaticoduodenectomy after Roux-en-Y gastric bypass: a systematic review. World J Surg Oncol. 2018;16:168.
Yamamoto M, Zaima M, Yamamoto H, Harada H, Kawamura J, Yamada M, et al. New laparoscopic procedure for left-sided pancreatic cancer-artery-first approach laparoscopic RAMPS using 3D technique. World J Surg Oncol. 2017;15:213.
Wu T, Guo Y, Bi J, Liu S, Guo Y, Bao S. Modified duct-to-mucosa versus conventional pancreaticoenterostomy for pancreaticoduodenectomy: a retrospective cohort study based on propensity score matching analysis. World J Surg Oncol. 2019;17:5.
Wang D, Liu X, Wu H, Liu K, Zhou X, Liu J, et al. Clinical evaluation of modified invaginated pancreaticojejunostomy for pancreaticoduodenectomy. World J Surg Oncol. 2020;18:75.
Liu M, Ji S, Xu W, Liu W, Qin Y, Hu Q, et al. Laparoscopic pancreaticoduodenectomy: are the best times coming? World J Surg Oncol. 2019;17:81.
Ji WB, Wang HG, Zhao ZM, Duan WD, Lu F, Dong JH. Robotic-assisted laparoscopic anatomic hepatectomy in China: initial experience. Ann Surg. 2011;253:342–8.
Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Nagino M. Review of hepatopancreatoduodenectomy for biliary cancer: an extended radical approach of Japanese origin. J Hepatobiliary Pancreat Sci. 2014;21:550–5.
Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y, et al. Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients. Ann Surg. 2012;256:297–305.
Fang Y, Gurusamy KS, Wang Q, Davidson BR, Lin H, Xie X, et al. Meta-analysis of randomized clinical trials on safety and efficacy of biliary drainage before surgery for obstructive jaundice. Br J Surg. 2013;100:1589–96.
Vauthey JN, Pawlik TM, Abdalla EK, Arens JF, Nemr RA, Wei SH, et al. Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg. 2004;239:722–30.
Iacono C, Ruzzenente A, Campagnaro T, Bortolasi L, Valdegamberi A, Guglielmi A. Role of preoperative biliary drainage in jaundiced patients who are candidates for pancreatoduodenectomy or hepatic resection: highlights and drawbacks. Ann Surg. 2013;257:191–204.
Ethics approval and consent to participate
This study was approved by the committee of The First Affiliated Hospital of Henan University of Science and Technology. The patient gave a written consent to participate in this trial.
Consent to publication
The author declares no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Yao, GL. Laparoscopic hepatopancreaticoduodenectomy for synchronous gallbladder cancer and extrahepatic cholangiocarcinoma: a case report. World J Surg Onc 20, 190 (2022). https://doi.org/10.1186/s12957-022-02628-9
- Hepatopancreatoduodenectomy laparoscopy
- Gallbladder cancer
- Extrahepatic cholangiocarcinoma